BI Asset Management Fondsmaeglerselskab A/S
Position in PTCT — Ptc Therapeutics, Inc.
CIK 1778131
KOBENHAVN, G7
Position in PTCT
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$5,578,348
-$6,535,524 QoQ
Shares Held
81,878
-48.7% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $75,123,826 across 13 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,137 | $17,453,602 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
206,563 | $16,167,686 | |
| 3 | EXEL |
Exelixis, Inc.
|
274,867 | $14,955,513 | |
| 4 | INCY |
Incyte Corp
|
113,231 | $12,835,866 | |
| 5 | INSM |
INSMED Inc
|
46,033 | $4,908,038 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,132 | $3,200,007 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,097 | $2,136,409 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
25,727 | $2,039,893 |
All Filings in PTCT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,578,348 | 81,878 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $12,113,872 | 159,477 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,830,456 | 95,005 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $6,159,700 | 126,120 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $60,897 | 1,195 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||